Measured Wealth Private Client Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Measured Wealth Private Client Group's AMGN Position: Q2 2026 in Review
Measured Wealth Private Client Group reduced its Amgen (AMGN) stake by 2.9% in Q2 2026, selling an estimated $8.9K and leaving 879 shares worth $318K. The position accounts for 0.08% of the portfolio, ranked #147.
Measured Wealth Private Client Group first reported a position in AMGN in Q2 2018 and has held it in 29 quarters since. The position peaked at $583K in Q2 2021. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Measured Wealth Private Client Group held 879 shares of Amgen worth $318K as of Q2 2026.
- Measured Wealth Private Client Group sold 26 Amgen shares in Q2 2026, an estimated $8.9K.
- Amgen made up 0.08% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #147 holding.
- Measured Wealth Private Client Group first reported a position in Amgen in Q2 2018 and has held it in 29 quarters since.
- Measured Wealth Private Client Group's Amgen position peaked at $583K in Q2 2021.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.